Total Positions
12
Quarter
2025 Q4
Top Holding
VEU (59.5%)
Top 10 Concentration
99.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-12 of 12
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
VEU
VANGUARD INTL E...
|
ETF | 59.53% | 77.31% |
#1
Prev: #1
|
10.0 | 411,900 | 16.0% |
P
S
|
2,990,084 | $219,950,579 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VTV
VANGUARD INDEX ...
|
ETF | 26.88% | — |
#2
Prev: #—
|
10.0 | 520,000 | no change |
NEW
|
520,000 | $99,314,800 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INDA
ISHARES TR
|
ETF | 5.41% | 8.08% |
#3
1
Prev: #2
|
2.2 | no change | no change |
P
S
|
369,600 | $19,976,880 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FHTX
FOGHORN THERAPE...
|
Healthcare | 2.30% | 3.23% |
#4
Prev: #4
|
0.9 | no change | no change |
P
S
|
1,573,761 | $8,498,309 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 2.19% | 4.99% |
#5
2
Prev: #3
|
0.9 | no change | no change |
P
S
|
989,410 | $8,093,374 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PMVP
PMV PHARMACEUTI...
|
Healthcare | 0.89% | 1.55% |
#6
Prev: #6
|
0.4 | no change | no change |
P
S
|
2,627,643 | $3,284,554 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SPY
SPDR S&P 500 ET...
|
ETF | 0.76% | 1.15% |
#7
Prev: #7
|
0.3 | no change | no change |
P
S
|
4,104 | $2,798,600 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 0.75% | 0.89% |
#8
Prev: #8
|
0.3 | no change | no change |
P
S
|
82,234 | $2,785,266 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALEC
ALECTOR INC
|
Healthcare | 0.55% | 1.63% |
#9
4
Prev: #5
|
0.2 | no change | no change |
P
S
|
1,307,858 | $2,040,258 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRZN
SURROZEN INC
|
Healthcare | 0.54% | 0.47% |
#10
Prev: #10
|
0.2 | no change | no change |
P
S
|
87,696 | $1,981,930 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TNYA
TENAYA THERAPEU...
|
Healthcare | 0.20% | 0.69% |
#11
2
Prev: #9
|
0.1 | no change | no change |
P
S
|
1,015,705 | $722,674 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRZNW
SURROZEN INC
|
Unknown | 0.00% | 0.00% |
#12
1
Prev: #11
|
0.0 | no change | no change |
P
S
|
170,833 | $3,417 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-12 of 12 holdings